GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invictus MD Strategies Corp (OTCPK:IVITF) » Definitions » Earnings per Share (Diluted)

Invictus MD Strategies (Invictus MD Strategies) Earnings per Share (Diluted) : $-0.24 (TTM As of Oct. 2019)


View and export this data going back to 2015. Start your Free Trial

What is Invictus MD Strategies Earnings per Share (Diluted)?

Invictus MD Strategies's Earnings per Share (Diluted) for the three months ended in Oct. 2019 was $-0.04. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2019 was $-0.24.

Invictus MD Strategies's EPS (Basic) for the three months ended in Oct. 2019 was $-0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Oct. 2019 was $-0.24.

Invictus MD Strategies's EPS without NRI for the three months ended in Oct. 2019 was $-0.05. Its EPS without NRI for the trailing twelve months (TTM) ended in Oct. 2019 was $-0.17.


Invictus MD Strategies Earnings per Share (Diluted) Historical Data

The historical data trend for Invictus MD Strategies's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invictus MD Strategies Earnings per Share (Diluted) Chart

Invictus MD Strategies Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19
Earnings per Share (Diluted)
-0.18 -0.02 -0.41 -0.23 -0.26

Invictus MD Strategies Quarterly Data
Jan15 Apr15 Jul15 Oct15 Jan16 Apr16 Jul16 Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.10 -0.03 -0.08 -0.04

Competitive Comparison of Invictus MD Strategies's Earnings per Share (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Invictus MD Strategies's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Invictus MD Strategies's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Invictus MD Strategies's PE Ratio distribution charts can be found below:

* The bar in red indicates where Invictus MD Strategies's PE Ratio falls into.



Invictus MD Strategies Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Invictus MD Strategies's Earnings Per Share (Diluted) for the fiscal year that ended in Jan. 2019 is calculated as

Diluted Earnings Per Share (A: Jan. 2019 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-26.851-0)/101.588
=-0.26

Invictus MD Strategies's Earnings Per Share (Diluted) for the quarter that ended in Oct. 2019 is calculated as

Diluted Earnings Per Share (Q: Oct. 2019 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-4.998-0)/124.583
=-0.04

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2019 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Invictus MD Strategies  (OTCPK:IVITF) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Invictus MD Strategies Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Invictus MD Strategies's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Invictus MD Strategies (Invictus MD Strategies) Business Description

Traded in Other Exchanges
N/A
Address
595 Burrard Street, 16th floor, Vancouver, BC, CAN, V7X 1J1
Invictus MD Strategies Corp is a cannabis company with a focus on the Canadian cannabis space, offering a selection of products under a wide range of cannabinoid profiles that fit the demand of the company's medical clients and retail customers. Its wholly-owned subsidiary's Phase I and Phase II facilities are in full production. The company's 50% owned subsidiary has completed its Phase II expansion and received its amended license from Health Canada. Another of its wholly owned subsidiary, connects medical clients to physicians for medical cannabis.

Invictus MD Strategies (Invictus MD Strategies) Headlines